Evidence map›Paper›PMID 34638217›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Advances in the study of the role of adenosine 2A receptor in liver injury].

Y L Cai, X L Chen, B Yi, J F Li, Z Y Wen, Y A Jiang

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Y L CaiDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
X L ChenDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
B YiDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
J F LiDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Z Y WenDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Y A JiangDepartment of Infectious Disease, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Renmin Hospital of Wuhan University · CNWuhan University · CN

Funding

Natural Science Foundation of Hubei Province 2018CFB140
6 · The paper itself

Abstract

Adenosine, as an endogenous purine nucleoside, is widely distributed in various tissues and organs of the body. It binds to adenosine receptors to regulate a variety of important biological processes. Adenosine 2A receptors have a close relationship with the occurrence and development of various clinical diseases. This article reviews the research progress of adenosine 2A receptors in non-alcoholic fatty liver disease, acute immune hepatitis, liver ischemia-reperfusion injury, liver fibrosis, etc., in order to provide new research strategies for the prevention and treatment of these diseases.

Indexed as

Receptors, Purinergic P1Reperfusion InjuryAdenosineHumansLiver CirrhosisAdenosineReceptors, Purinergic P1AdenosineAdenosine 2a receptorLiver

Identifiers

PMID34638217
PMCPMC12814152
OpenAlexW3206005896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.